Zymergen integrates computational and manufacturing technologies to design, develop, and commercialize bio-based breakthrough products in a range of industries. Co. has developed a platform based on its collection of accessible biomolecules, its software and data science technology and its data driven microbe optimization processes. Utilizing its platform, Co. is building several businesses, including: advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products; and drug discovery, which utilizes its differentiated access to natural products as a source of chemical matter provided by its unified metagenomics database. We show 7 historical shares outstanding datapoints in our coverage of ZY's shares outstanding history.
Understanding the changing numbers of ZY shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ZY versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ZY by allowing them to research ZY shares outstanding history
as well as any other stock in our coverage universe. |
Free ZY Email Alerts:
Video: Shares Outstanding Importance
